Earlier this month, Swiss drug major Novartis India passed on the sales and distribution rights of three of its established brands to Dr Reddys Labs and terminated the employment of…
New Delhi: Leaders across pharma industries shared their views on innovation, technology and the potential learnings for the pharmaceutical industry and deliberated on achieving excellence and quality in operations, vaccine…
Drug maker Cipla said it isn’t seeing much demand for drugs such as remdesivir, tocilizumab, favipiravir and certain inhaled corticosteroids that were driving its sales in the second wave of…
Drugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become the number one company in lung specialty. Currently, GSK,…
